Ran Tian
Tianjin Medical University Cancer Institute and Hospital(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, S100 Proteins and Annexins, Drug Transport and Resistance Mechanisms, Extracellular vesicles in disease
Most-Cited Works
- → Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity(2005)313 cited
- → Fabrication of Self-Healing Hydrogels with On-Demand Antimicrobial Activity and Sustained Biomolecule Release for Infected Skin Regeneration(2018)196 cited
- → TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways(2017)177 cited
- → Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation(2020)173 cited
- → The development of low-molecular weight hydrogels for applications in cancer therapy(2013)104 cited
- → A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced Immunotherapy(2023)100 cited
- → Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution(2021)100 cited
- → Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells(2015)94 cited
- → Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles(2023)91 cited
- → Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer(2020)89 cited